BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 13
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6614)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-9) series.
Item 
Count 
PDF610
HTML5718
Figures (1-4)144
Tables (1-9)142
 Sum=6614
Apr 7, 2009 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009; 15(13): 1554-1580 [PMID: 19340897 DOI: 10.3748/wjg.15.1554]
URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1554.htm
Number Citing Articles
1
Jiaying Huo, Ziyan Wu, Weizheng Sun, Zhenhua Wang, Jihong Wu, Mingquan Huang, Bowen Wang, Baoguo Sun. Protective Effects of Natural Polysaccharides on Intestinal Barrier Injury: A Review. Journal of Agricultural and Food Chemistry 2022; 70(3): 711 doi: 10.1021/acs.jafc.1c05966
2
Sharon X. H. Hu, Adel Ekladious. Common presentation of an uncommon disease. Internal Medicine Journal 2021; 51(12): 2153 doi: 10.1111/imj.15619
3
Akihiro FUJIMOTO, Hirokazu SUWA, Jun WATANABE, Masatoshi MOGAKI, Hidenobu MASUI, Kaoru NAGAHORI. A Case of Small Intestinal Fulminant Clostridium <I>Difficile</I> Enteritis in which the Patient's Life was Saved by Small Bowel Resection. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2019; 80(1): 84 doi: 10.3919/jjsa.80.84
4
Hsiao-Lun Wei, Sung-Hsi Wei, Chien-Wen Huang, Chih-Hung Shih, Yi-Wen Huang, Min-Chi Lu, Jin-Chyr Hsu, Yi-Sheng Liou, Chien-Shun Chiou. Molecular typing and epidemiology of Clostridium difficile in respiratory care wards of central Taiwan. Journal of Microbiology, Immunology and Infection 2015; 48(1): 65 doi: 10.1016/j.jmii.2013.03.014
5
Ralph B. D'Agostino, Sylva H. Collins, Karol M. Pencina, Yin Kean, Sherwood Gorbach. Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors. Clinical Infectious Diseases 2014; 58(10): 1386 doi: 10.1093/cid/ciu107
6
Ethan Gough, Henna Shaikh, Amee R. Manges. Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection. Clinical Infectious Diseases 2011; 53(10): 994 doi: 10.1093/cid/cir632
7
Thais Simões Camargo, Moacyr Silva Junior, Luis Fernando Aranha Camargo, Veronica Pivetta Biotto, André Mario Doi, Paula Celia Mariko Koga, Carolina Nunes França, Marines Dalla Valle Martino. Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods. Archives of Microbiology 2021; 203(4): 1683 doi: 10.1007/s00203-020-02148-8
8
Chaitanya Pant, Thomas J. Sferra, Abhishek Deshpande, Anil Minocha. Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner. European Journal of Internal Medicine 2011; 22(6): 561 doi: 10.1016/j.ejim.2011.04.009
9
Yvonne Kleypas, Dennis McCubbin, Elizabeth S. Curnow. The Role of Environmental Cleaning in Health Care-Associated Infections. Critical Care Nursing Quarterly 2011; 34(1): 11 doi: 10.1097/CNQ.0b013e31820480d3
10
A. Barney Hawthorne. Toxic dilatation of the colon. Medicine 2019; 47(4): 237 doi: 10.1016/j.mpmed.2019.01.006
11
Massimo Sartelli, Mark A. Malangoni, Fikri M. Abu-Zidan, Ewen A. Griffiths, Stefano Di Bella, Lynne V. McFarland, Ian Eltringham, Vishal G. Shelat, George C. Velmahos, Ciarán P. Kelly, Sahil Khanna, Zaid M. Abdelsattar, Layan Alrahmani, Luca Ansaloni, Goran Augustin, Miklosh Bala, Frédéric Barbut, Offir Ben-Ishay, Aneel Bhangu, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Laura A. Canterbury, Fausto Catena, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria Elena Cocuz, Raul Coimbra, Charles H. Cook, Yunfeng Cui, Jacek Czepiel, Koray Das, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina Magdalena Dumitru, Catherine Eckert, Christian Eckmann, Edward H. Eiland, Mushira Abdulaziz Enani, Mario Faro, Paula Ferrada, Joseph Derek Forrester, Gustavo P. Fraga, Jean Louis Frossard, Rita Galeiras, Wagih Ghnnam, Carlos Augusto Gomes, Venkata Gorrepati, Mohamed Hassan Ahmed, Torsten Herzog, Felicia Humphrey, Jae Il Kim, Arda Isik, Rao Ivatury, Yeong Yeh Lee, Paul Juang, Luis Furuya-Kanamori, Aleksandar Karamarkovic, Peter K Kim, Yoram Kluger, Wen Chien Ko, Francis D. LaBarbera, Jae Gil Lee, Ari Leppaniemi, Varut Lohsiriwat, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick Alan Moore, Carl Erik Nord, Carlos A. Ordoñez, Gerson Alves Pereira Júnior, Nicola Petrosillo, Francisco Portela, Basant K. Puri, Arnab Ray, Mansoor Raza, Miran Rems, Boris E. Sakakushev, Gabriele Sganga, Patrizia Spigaglia, David B. Stewart, Pierre Tattevin, Jean Francois Timsit, Kathleen B. To, Cristian Tranà, Waldemar Uhl, Libor Urbánek, Harry van Goor, Angela Vassallo, Jean Ralph Zahar, Emanuele Caproli, Pierluigi Viale. WSES guidelines for management of Clostridium difficile infection in surgical patients. World Journal of Emergency Surgery 2015; 10(1) doi: 10.1186/s13017-015-0033-6
12
M. Kazanowski, S. Smolarek, F. Kinnarney, Z. Grzebieniak. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities—a systematic review. Techniques in Coloproctology 2014; 18(3): 223 doi: 10.1007/s10151-013-1081-0
13
Hye Sun Park, Dong Soo Han. Management of Antibiotics-Associated Diarrhea. The Korean Journal of Gastroenterology 2009; 54(1): 5 doi: 10.4166/kjg.2009.54.1.5
14
Kirsty Skinner, Stephen Birchall, David Corbett, Pia Thommes, Hans H. Locher. Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile. Journal of Medical Microbiology 2018; 67(9): 1402 doi: 10.1099/jmm.0.000808
15
Veroljub Marković, Marina Kostić, Ivana Iličković, Slobodan M. Janković. Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition. Value in Health Regional Issues 2014; 4: 87 doi: 10.1016/j.vhri.2014.08.001
16
Sergey S. Seregin, Yasser A. Aldhamen, David P.W. Rastall, Sarah Godbehere, Andrea Amalfitano. Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice. Vaccine 2012; 30(8): 1492 doi: 10.1016/j.vaccine.2011.12.064
17
Bruce E Hirsch, Nimit Saraiya, Kaitlin Poeth, Rebecca M Schwartz, Marcia E Epstein, Gerard Honig. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0930-z
18
Diagnostic Pathology: Gastrointestinal. 2016; : 422 doi: 10.1016/B978-0-323-37673-0.50122-1
19
Eunhak Seong, Sookyoung Lim, Myeongjong Lee, Hojun Kim. A Study of Antimicrobial Activity of Herbal Extracts on Clostridium difficile. Journal of Korean Medicine Rehabilitation 2021; 31(1): 47 doi: 10.18325/jkmr.2021.31.1.47
20
Mayuresh M. Abhyankar, Jennie Z. Ma, Kenneth W. Scully, Andrew J. Nafziger, Alyse L. Frisbee, Mahmoud M. Saleh, Gregory R. Madden, Ann R. Hays, Mendy Poulter, William A. Petri, Martin J. Blaser. Immune Profiling To Predict Outcome of Clostridioides difficile Infection. mBio 2020; 11(3) doi: 10.1128/mBio.00905-20
21
J. B. Rosen, M. G. Schecter, J. S. Heinle, E. D. McKenzie, D. L. Morales, M. K. Dishop, L. Danziger-Isakov, G. B. Mallory, O. Elidemir. Clostridium difficile colitis in children following lung transplantation. Pediatric Transplantation 2010; 14(5): 651 doi: 10.1111/j.1399-3046.2010.01314.x
22
Leila Zarepoor, Jenifer T. Lu, Claire Zhang, Wenqing Wu, Dion Lepp, Lindsay Robinson, Janitha Wanasundara, Steve Cui, Sébastien Villeneuve, Bourlaye Fofana, Rong Tsao, Geoffrey A. Wood, Krista A. Power. Dietary flaxseed intake exacerbates acute colonic mucosal injury and inflammation induced by dextran sodium sulfate. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(12): G1042 doi: 10.1152/ajpgi.00253.2013
23
S. Buyse, V. Peigne, M. Darmon, V. Lemiale, N. Munoz-Bongrand, B. Schlemmer, E. Azoulay. Réanimation hépatosplanchnique. 2010; : 291 doi: 10.1016/B978-2-8101-0186-3.50021-7
24
Daniel Paredes-Sabja, Mahfuzur R. Sarker. Adherence of Clostridium difficile spores to Caco-2 cells in culture.  Journal of Medical Microbiology 2012; 61(9): 1208 doi: 10.1099/jmm.0.043687-0
25
Hidekazu TAKATSUKA, Taro SASAYAMA, Nao TAKAKI. . Japanese Journal of Environmental Infections 2010; 25(5): 272 doi: 10.4058/jsei.25.272
26
Yuichi Muraki, Masaki Tanabe, Akiko Nakamura, Yoshiko Matsushima, Masayuki Senoo, Midori Fukuda, Masahiro Okuda. Evaluation of Hospital Information System-linked Notification System Concerning Usage of Broad-Spectrum Antimicrobials. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2010; 36(5): 316 doi: 10.5649/jjphcs.36.316
27
Gustavo Hideki Kawanami, Carlos Magno Castelo Branco Fortaleza. Factors predictive of inappropriateness in requests for parenteral antimicrobials for therapeutic purposes: A study in a small teaching hospital in Brazil. Scandinavian Journal of Infectious Diseases 2011; 43(6-7): 528 doi: 10.3109/00365548.2011.565795
28
Elisabetta Antonelli, Monia Baldoni, Paolo Giovenali, Vincenzo Villanacci, Murad Essatari, Gabrio Bassotti. Intestinal superinfections in patients with inflammatory bowel diseases. Journal of Crohn's and Colitis 2012; 6(2): 154 doi: 10.1016/j.crohns.2011.07.012
29
Seth Squires, Allan Boal, Fiona McCluskey. A ward nurse's guide to inflammatory bowel disease (part 1): screening, observation and investigation. Gastrointestinal Nursing 2018; 16(6): 32 doi: 10.12968/gasn.2018.16.6.32
30
M. Schmidt-Hieber, J. Bierwirth, D. Buchheidt, O. A. Cornely, M. Hentrich, G. Maschmeyer, E. Schalk, J. J. Vehreschild, Maria J. G. T. Vehreschild. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of Hematology 2018; 97(1): 31 doi: 10.1007/s00277-017-3183-7
31
Mónica Millán Scheiding, Jose Sáez Hernandez, Jaime López Borao, Jordi Guardiola Capón, Sebastiano Biondo. Colitis fulminante por Clostridium difficile. Cirugía Española 2011; 89(8): 556 doi: 10.1016/j.ciresp.2010.05.022
32
Mary Ann Jessee. Stool Studies: Tried, True, and New. Critical Care Nursing Clinics of North America 2010; 22(1): 129 doi: 10.1016/j.ccell.2009.10.006
33
Manuel Ferrer Márquez, Álvaro Hernández Martínez, Ángel Reina Duarte, Rafael Rosado Cobián. Estado actual del tratamiento de la colitis fulminante. Cirugía Española 2015; 93(5): 276 doi: 10.1016/j.ciresp.2014.09.016
34
Matthias A. Oberli, Marie-Lyn Hecht, Pascal Bindschädler, Alexander Adibekian, Thomas Adam, Peter H. Seeberger. A Possible Oligosaccharide-Conjugate Vaccine Candidate for Clostridium difficile Is Antigenic and Immunogenic. Chemistry & Biology 2011; 18(5): 580 doi: 10.1016/j.chembiol.2011.03.009
35
Pamela R. Walters, Brian S. Zuckerbraun. Clostridium difficile Infection: Clinical Challenges and Management Strategies. Critical Care Nurse 2014; 34(4): 24 doi: 10.4037/ccn2014822
36
Hugo J.R. Bonatti, Jessica L. Hata, Michael A. Vella, Chanjuan Shi, William H. Nealon, Addison K. May. Failure to Recognize the Diagnosis of Cytomegalovirus Colitis in an Immunocompetent Male: Need for Heightened Index of Suspicion. Surgical Infections Case Reports 2016; 1(1): 156 doi: 10.1089/crsi.2016.0039
37
Anastasia S. Ivanova, Olga A Obukhova. Nutritional support as a part of complex therapy for clostridial infection. Clinical nutrition and metabolism 2024;  doi: 10.17816/clinutr623270
38
Kazuaki Matsumoto, Naoko Kanazawa, Akari Shigemi, Kazuro Ikawa, Norifumi Morikawa, Toyoyasu Koriyama, Michiyo Orita, Hideki Kawamura, Koichi Tokuda, Junichiro Nishi, Yasuo Takeda. Factors Affecting Treatment and Recurrence of <i>Clostridium difficile</i> Infections. Biological and Pharmaceutical Bulletin 2014; 37(11): 1811 doi: 10.1248/bpb.b14-00492
39
Clinical Guideline for the Diagnosis and Treatment of Gastrointestinal Infections. Infection and Chemotherapy 2010; 42(6): 323 doi: 10.3947/ic.2010.42.6.323
40
Preetika Sinh, Terrence A. Barrett, Laura Yun. Clostridium difficileInfection and Inflammatory Bowel Disease: A Review. Gastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/136064
41
Courtney R. Murphy, Taliser R. Avery, Erik R. Dubberke, Susan S. Huang. Frequent Hospital Readmissions for Clostridium difficile Infection and the Impact on Estimates of Hospital-Associated C. difficile Burden. Infection Control & Hospital Epidemiology 2012; 33(1): 20 doi: 10.1086/663209
42
David C. Kaslow, John W. Shiver. Clostridium difficile and Methicillin-Resistant Staphylococcus aureus: Emerging Concepts in Vaccine Development. Annual Review of Medicine 2011; 62(1): 201 doi: 10.1146/annurev-med-051109-101544
43
Declan Bolton, Pilar Marcos. The Environment, Farm Animals and Foods as Sources of Clostridioides difficile Infection in Humans. Foods 2023; 12(5): 1094 doi: 10.3390/foods12051094
44
Chang Soo Eun, Dong Soo Han. Advances in Endoscopy in Inflammatory Bowel Disease. 2018; : 137 doi: 10.1007/978-4-431-56018-0_13
45
Hsiao L Wei, Chun Wei Kao, Sung H Wei, Jason TC Tzen, Chien S Chiou. Comparison of PCR ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) for improved detection of Clostridium difficile. BMC Microbiology 2011; 11(1) doi: 10.1186/1471-2180-11-217
46
Gösta Lotz, Jan Kloka, Linda Vo, Helga Häfner, Simone Scheithauer, Sebastian Lemmen. Die Intensivmedizin. Springer Reference Medizin 2023; : 1 doi: 10.1007/978-3-642-54675-4_83-2
47
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Hsin-Bai Yin, Shankumar Mooyottu, Kumar Venkitanarayanan. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile. Journal of Medical Microbiology 2019; 68(7): 1118 doi: 10.1099/jmm.0.001008
48
Sue Jung Kim, Heejung Kim, Younghee Seo, Dongeun Yong, Seok Hoon Jeong, Yunsop Chong, Kyungwon Lee. Molecular characterization of toxin A-negative, toxin B-positive variant strains of Clostridium difficile isolated in Korea. Diagnostic Microbiology and Infectious Disease 2010; 67(2): 198 doi: 10.1016/j.diagmicrobio.2010.01.007
49
Dukyong Yoon, Inwhee Park, Martijn J. Schuemie, Man Young Park, Ju Han Kim, Rae Woong Park, Indra Neil Sarkar. A Quantitative Method for Assessment of Prescribing Patterns Using Electronic Health Records. PLoS ONE 2013; 8(10): e75214 doi: 10.1371/journal.pone.0075214
50
Lena M. Napolitano, Charles E. Edmiston. Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update. Surgery 2017; 162(2): 325 doi: 10.1016/j.surg.2017.01.018
51
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Deepa Ashwarya Kuttappan, Neha Mishra, Breno de Oliveira Fragomeni, Kendra Maas, Shankumar Mooyottu, Kumar Venkitanarayanan. Protective Effect of Baicalin against Clostridioides difficile Infection in Mice. Antibiotics 2021; 10(8): 926 doi: 10.3390/antibiotics10080926
52
Marinko Marušić. Is there a Connection between Inflammatory Bowel Disease Exacerbation, Clostridium difficile Infection and Thrombocytosis?. Archives of Clinical Gastroenterology 2016; : 034 doi: 10.17352/2455-2283.000017
53
H. Häfner, S. Scheithauer, S. Lemmen. Die Intensivmedizin. 2015; : 1 doi: 10.1007/978-3-642-54675-4_83-1
54
Guillermo Alvarez-Calatayud, Abelardo Margolles. Dual-coated lactic acid bacteria: an emerging innovative technology in the field of probiotics. Future Microbiology 2016; 11(3): 467 doi: 10.2217/fmb.15.150
55
M.R. Canales-Simón, M.J. Gil de Gómez-Barragán, A.M. Vázquez Medrano. Colitis pseudomembranosa en atención primaria. SEMERGEN - Medicina de Familia 2010; 36(10): 593 doi: 10.1016/j.semerg.2010.04.007
56
Cristian Hernández-Rocha, Jonathan Barra-Carrasco, Manuel Álvarez-Lobos, Daniel Paredes-Sabja, Ana María Guzmán-Durán. Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile–associated infections. Diagnostic Microbiology and Infectious Disease 2013; 75(4): 361 doi: 10.1016/j.diagmicrobio.2012.12.010
57
Jennifer L. Cribb, Karly O'Brien, Christina E. DeRemer. Rifaximin in Combination with Metronidazole and Oral Vancomycin for the Treatment of an Initial Episode of Clostridium difficile–Associated Diarrhea: Case Report and Literature Review. Hospital Pharmacy 2012; 47(3): 206 doi: 10.1310/hpj4703-206
58
Fred C. Tenover, Thomas Åkerlund, Dale N. Gerding, Richard V. Goering, Therése Boström, Anna-Maria Jonsson, Edith Wong, Alan T. Wortman, David H. Persing. Comparison of Strain Typing Results for Clostridium difficile Isolates from North America. Journal of Clinical Microbiology 2011; 49(5): 1831 doi: 10.1128/JCM.02446-10
59
Kiran K. Maddu, Pardeep Mittal, Waqas Shuaib, Anuj Tewari, Oluwayemisi Ibraheem, Faisal Khosa. Colorectal Emergencies and Related Complications: A Comprehensive Imaging Review—Imaging of Colitis and Complications. American Journal of Roentgenology 2014; 203(6): 1205 doi: 10.2214/AJR.13.12250
60
Jodie A. Barkin, Neilanjan Nandi, Nancimae Miller, Alexandra Grace, Jamie S. Barkin, Daniel A. Sussman. Superiority of the DNA Amplification Assay for the Diagnosis of C. difficile Infection: A Clinical Comparison of Fecal Tests. Digestive Diseases and Sciences 2012; 57(10): 2592 doi: 10.1007/s10620-012-2200-x
61
Rebecca J. Swett, G. Andrés Cisneros, Andrew L. Feig. Disruption of Intrinsic Motions as a Mechanism for Enzyme Inhibition. Biophysical Journal 2013; 105(2): 494 doi: 10.1016/j.bpj.2013.05.031
62
TaeGyun Kim, MinJu Kim, JunHyung Lee, Joseph Moturi, SangHun Ha, Habeeb Tajudeen, JunYoung Mun, Abdolreza Hosseindoust, ByungJo Chae. Supplementation of nano-zinc in lower doses as an alternative to pharmacological doses of ZnO in weanling pigs. Journal of Animal Science and Technology 2022; 64(1): 70 doi: 10.5187/jast.2022.e2
63
Hiroshige Mikamo, Kazuhiro Tateda, Katsunori Yanagihara, Shinya Kusachi, Yoshio Takesue, Takashi Miki, Yuki Oizumi, Kazuaki Gamo, Atsuki Hashimoto, Junko Toyoshima, Kenichi Kato. Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan. Journal of Infection and Chemotherapy 2018; 24(9): 744 doi: 10.1016/j.jiac.2018.05.010
64
Olga Sklenickova, Jaroslav Flesar, Ladislav Kokoska, Eva Vlkova, Katerina Halamova, Jan Malik. Selective Growth Inhibitory Effect of Biochanin A Against Intestinal Tract Colonizing Bacteria. Molecules 2010; 15(3): 1270 doi: 10.3390/molecules15031270
65
Ana E. Pérez-Cobas, Alejandro Artacho, Stephan J. Ott, Andrés Moya, María J. Gosalbes, Amparo Latorre. Structural and functional changes in the gut microbiota associated to Clostridium difficile infection. Frontiers in Microbiology 2014; 5 doi: 10.3389/fmicb.2014.00335
66
Cormac Magee, Victoria Blackwell, Simon Travis. Toxic dilatation of the colon. Medicine 2015; 43(3): 171 doi: 10.1016/j.mpmed.2014.12.007
67
Beth A. Houser, Arthur L. Hattel, Bhushan M. Jayarao. Real-Time Multiplex Polymerase Chain Reaction Assay for Rapid Detection ofClostridium difficileToxin-Encoding Strains. Foodborne Pathogens and Disease 2010; 7(6): 719 doi: 10.1089/fpd.2009.0483
68
Disaya Chavalitdhamrong, Gary C. Chen, Rome Jutabha. Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. 2010; : 312 doi: 10.1002/9781444328417.ch44
69
C Vaishnavi. ESTABLISHED AND POTENTIAL RISK FACTORS FOR CLOSTRIDUM DIFFICILE INFECTION. Indian Journal of Medical Microbiology 2009; 27(4): 289 doi: 10.4103/0255-0857.55436
70
Syed Rahmanuddin, Daniel D. Von Hoff, Ammar Chaudhry, Danielle Guidaben, Marjaan Khan, William Boswell, Derek Cridebring, Jordyn Brase, Yuman Fong, Pejman Motarjem, Erkut Borazanci. Utilization of a novel 3D radiologic scoring method to define therapeutic response and surgical candidacy. Frontiers in Imaging 2023; 2 doi: 10.3389/fimag.2023.1117798
71
Dong Kil Na, Jin Bae Kim, Young Chul Shin, Su Lin Shin, Hyo Jung Kim, Il Hyun Baek, Sang Hoon Park, Myung Seok Lee. Left-sided Ulcerative Colitis Reactivated and Aggravated duringClostridium difficileInfection. The Korean Journal of Gastroenterology 2011; 57(6): 374 doi: 10.4166/kjg.2011.57.6.374
72
Cynthia Susai, Julie Monteagudo, Francois I. Luks. Controversies in Pediatric Appendicitis. 2019; : 119 doi: 10.1007/978-3-030-15006-8_13
73
Hedley S. Roth, Christopher T. Parker, Roger J. Wale, Satish K. Warrier. Clostridium difficile-associated disease: how much do we really know? A single institution study. Healthcare infection 2014; 19(4): 122 doi: 10.1071/HI14031
74
Manuel Ferrer Márquez, Álvaro Hernández Martínez, Ángel Reina Duarte, Rafael Rosado Cobián. Current Status of the Treatment of Fulminant Colitis. Cirugía Española (English Edition) 2015; 93(5): 276 doi: 10.1016/j.cireng.2014.09.009
75
Theodore Rokkas, Javier P Gisbert, Antonio Gasbarrini, Georgina L Hold, Herbert Tilg, Peter Malfertheiner, Francis Megraud, Colm O'Morain. A network meta‐analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection. United European Gastroenterology Journal 2019; 7(8): 1051 doi: 10.1177/2050640619854587
76
M. J. Aldape, D. D. Heeney, A. E. Bryant, D. L. Stevens. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile. Journal of Antimicrobial Chemotherapy 2015; 70(1): 153 doi: 10.1093/jac/dku325
77
Chetana Vaishnavi. Clostridium difficile infection: clinical spectrum and approach to management. Indian Journal of Gastroenterology 2011; 30(6): 245 doi: 10.1007/s12664-011-0148-y
78
Bogdan Arsic, Momcilo Pavlovic, Karolina Berenji. Risk Factors for Relapse and Mortality of Clostridium Difficile-Associated Diarrhea. Open Access Macedonian Journal of Medical Sciences 2014; 2(2): 249 doi: 10.3889/oamjms.2014.040
79
Sheela S. Reddy, Lawrence J. Brandt. Clostridium difficile Infection and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2013; 47(8): 666 doi: 10.1097/MCG.0b013e31828b288a
80
M. Beatriz Souza Dias, Juliana Yamashiro, Vera L. Borrasca, Valeska A. Stempliuk, Maria Rita E. Araújo, Silvia F. Costa, Anna S. Levin. Pseudo-outbreak of Clostridium difficile associated diarrhea (CDAD) in a tertiary-care hospital. Revista do Instituto de Medicina Tropical de São Paulo 2010; 52(3): 133 doi: 10.1590/S0036-46652010000300004
81
Ekaterina G. Semenyuk, Michelle L. Laning, Jennifer Foley, Pehga F. Johnston, Katherine L. Knight, Dale N. Gerding, Adam Driks, Peter Setlow. Spore Formation and Toxin Production in Clostridium difficile Biofilms. PLoS ONE 2014; 9(1): e87757 doi: 10.1371/journal.pone.0087757
82
Jerzy Karczewski, Julie Zorman, Su Wang, Matthew Miezeiewski, Jinfu Xie, Keri Soring, Ioan Petrescu, Irene Rogers, David S. Thiriot, James C. Cook, Mihaela Chamberlin, Rachel F. Xoconostle, Debbie D. Nahas, Joseph G. Joyce, Jean-Luc Bodmer, Jon H. Heinrichs, Susan Secore. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Vaccine 2014; 32(24): 2812 doi: 10.1016/j.vaccine.2014.02.026
83
Soledad M. Smith. An Update on Clostridium difficile Infection and its Management. Nursing for Women's Health 2010; 14(5): 391 doi: 10.1111/j.1751-486X.2010.01578.x
84
Priya D. Farooq, Nathalie H. Urrunaga, Derek M. Tang, Erik C. von Rosenvinge. Pseudomembranous colitis. Disease-a-Month 2015; 61(5): 181 doi: 10.1016/j.disamonth.2015.01.006
85
Diane M. Citron, Kerin L. Tyrrell, Suzanne E. Dale, Laurent Chesnel, Ellie J. C. Goldstein. Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial. Antimicrobial Agents and Chemotherapy 2016; 60(4): 2069 doi: 10.1128/AAC.02531-15
86
Shipeng Yu, Ahmed Abdelkarim, Ali Nawras, Bryan Thomas Hinch, Chimaka Mbaso, Shahul Valavoor, Fadi Safi, Jeffrey Hammersley, Jianlin Tang, Ragheb Assaly. Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular Dystrophy. American Journal of Therapeutics 2016; 23(2): e609 doi: 10.1097/MJT.0000000000000062
87
Stephen Harold, Herbert L. DuPont. Principles and Practice of Transplant Infectious Diseases. 2019; : 291 doi: 10.1007/978-1-4939-9034-4_16
88
Anca Trifan, Carol Stanciu, Oana Stoica, Irina Girleanu, Camelia Cojocariu. Impact of <italic>Clostridium difficile</italic> infection on inflammatory bowel disease outcome: A review. World Journal of Gastroenterology 2014; 20(33): 11736-11742 doi: 10.3748/wjg.v20.i33.11736
89
Eun Ae Cho, Kyung A Lee, Jae Song Kim, Soo Hyun Kim, Eun Sun Son. A Comparison of Vancomycin and Metronidazole for the Treatment ofClostridium difficile-associated Diarrhea (CDAD) in Medical Intensive Care Unit (MICU). Korean Journal of Clinical Pharmacy 2017; 27(2): 77 doi: 10.24304/kjcp.2017.27.2.77
90
Shankumar Mooyottu, Genevieve Flock, Abhinav Upadhyay, Indu Upadhyaya, Kendra Maas, Kumar Venkitanarayanan. Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.00625
91
FS Ahmadi, Z Rezaee, FD Tanha, S Nekuie, S Abbasi. Pseudomemberanous Colitis following Cesarean Delivery with Adjunctive Intracolonic Vancomycin. Journal of Gynecological Research and Obstetrics 2016; 2(1): 055 doi: 10.17352/jgro.000020
92
Ian R Poxton. Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections. Future Microbiology 2010; 5(4): 539 doi: 10.2217/fmb.10.20
93
J.D. Stanley, J.G. Bartlett, B.W. Dart, J.H. Ashcraft. Clostridium difficile infection. Current Problems in Surgery 2013; 50(7): 302 doi: 10.1067/j.cpsurg.2013.02.004
94
Shankumar Mooyottu, Genevieve Flock, Kumar Venkitanarayanan. Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro .  Journal of Medical Microbiology 2017; 66(8): 1229 doi: 10.1099/jmm.0.000515
95
Manuela Bianco, Giorgio Fedele, Adriano Quattrini, Patrizia Spigaglia, Fabrizio Barbanti, Paola Mastrantonio, Clara M. Ausiello. Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains.  Journal of Medical Microbiology 2011; 60(8): 1162 doi: 10.1099/jmm.0.029694-0
96
Mahfuzur R Sarker, Daniel Paredes-Sabja. Molecular basis of early stages of Clostridium difficile infection: germination and colonization. Future Microbiology 2012; 7(8): 933 doi: 10.2217/fmb.12.64
97
Hung Chan, Shan Zhao, Lin Zhang, Jeffery Ho, Czarina C.H. Leung, Wai T. Wong, Yuanyuan Tian, Xiaodong Liu, Thomas N.Y. Kwong, Raphael C.Y. Chan, Sidney S.B. Yu, Maggie H.T. Wang, Gary Tse, Sunny H. Wong, Matthew T.V. Chan, William K.K. Wu. Clostridium difficile toxin B induces autophagic cell death in colonocytes. Journal of Cellular and Molecular Medicine 2018; 22(4): 2469 doi: 10.1111/jcmm.13555
98
Timothy McGuire, Paul Dobesh, Don Klepser, Mark Rupp, Keith Olsen. Clinically important interaction between statin drugs and Clostridium difficile toxin?. Medical Hypotheses 2009; 73(6): 1045 doi: 10.1016/j.mehy.2009.06.058
99
Jacob R. Sweeney, Carl V. Crawford, Rhonda K. Yantiss. Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease. Histopathology 2022; 81(3): 312 doi: 10.1111/his.14702
100
Jae Hyun Park, Kyung Ji Kang, Yu Na Kang, Ae Suk Kim, Jin-Bok Hwang. Pseudomembranous colitis in children: Experience of a university hospital in Korea. Korean Journal of Pediatrics 2010; 53(2): 184 doi: 10.3345/kjp.2010.53.2.184
101
Helga Häfner, Sebastian Lemmen, Simone Scheithauer. Die Intensivmedizin. 2015; : 949 doi: 10.1007/978-3-642-54953-3_72
102
Chaitanya Pant, Abhishek Deshpande, Anne Larson, Judith O’Connor, David D.K. Rolston, Thomas J. Sferra. Diarrhea in solid-organ transplant recipients: a review of the evidence. Current Medical Research and Opinion 2013; 29(10): 1315 doi: 10.1185/03007995.2013.816278
103
Francisco Portela, Paula Lago. Fulminant colitis. Best Practice & Research Clinical Gastroenterology 2013; 27(5): 771 doi: 10.1016/j.bpg.2013.08.011
104
Toshio Ohshima, Takako Osaki, Yukari Yamamoto, Satomi Asai, Hayato Miyachi, Shigeru Kamiya, Andrew B. Onderdonk. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay. Journal of Clinical Microbiology 2018; 56(12) doi: 10.1128/JCM.00555-18
105
Murali K. Yanda, William B. Guggino, Liudmila Cebotaru. A new role for heat shock factor 27 in the pathophysiology of Clostridium difficile toxin B. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G120 doi: 10.1152/ajpgi.00166.2019
106
Hirotsugu Ozawa, Naoya Okada, Toru Nakamura, Minoru Takada, Yoshiyasu Ambo, Fumitaka Nakamura, Nobuichi Kashimura. A Case of Fulminant Clostridium difficile Colitis in Which Subtotal Colectomy Was Obviated by Performing Diverting Loop Ileostomy with Colonic Lavage. The Japanese Journal of Gastroenterological Surgery 2013; 46(12): 938 doi: 10.5833/jjgs.2013.0085
107
Akhil A. Vinithakumari, Piyush Padhi, Belen Hernandez, Susanne Je-Han Lin, Aaron Dunkerson-Kurzhumov, Lucas Showman, Matthew Breitzman, Caroline Stokes, Yousuf Sulaiman, Chandra Tangudu, Deepa A. Kuttappan, Muhammed S. Muyyarikkandy, Auriel A. Willette, Gregory J. Phillips, Vellareddy Anantharam, Ann Perera, Brett A. Sponseller, Anumantha Kanthasamy, Shankumar Mooyottu, Karen C. Carroll. Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism. Microbiology Spectrum 2022; 10(2) doi: 10.1128/spectrum.00073-22
108
Chaitanya Pant, Abhishek Deshpande, Muhammad A. Altaf, Anil Minocha, Thomas J. Sferra. Clostridium difficileinfection in children: a comprehensive review. Current Medical Research and Opinion 2013; 29(8): 967 doi: 10.1185/03007995.2013.803058
109
Sayf Al-Deen Hassouneh, Mark Loftus, Shibu Yooseph. Linking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.673632
110
Laura E. Raffals, Eugene B. Chang. Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel. Gut and Liver 2016; 10(4): 502 doi: 10.5009/gnl15491
111
Ana Raquel Maia, Rodrigo Reyes-Ramírez, Marjorie Pizarro-Guajardo, Anella Saggese, Pablo Castro-Córdova, Rachele Isticato, Ezio Ricca, Daniel Paredes-Sabja, Loredana Baccigalupi. Induction of a Specific Humoral Immune Response by Nasal Delivery of Bcla2ctd of Clostridioides difficile. International Journal of Molecular Sciences 2020; 21(4): 1277 doi: 10.3390/ijms21041277
112
B. Faris, A. Blackmore, N. Haboubi. Review of medical and surgical management of Clostridium difficile infection. Techniques in Coloproctology 2010; 14(2): 97 doi: 10.1007/s10151-010-0574-3
113
Monica Viladomiu, Raquel Hontecillas, Lijuan Yuan, Pinyi Lu, Josep Bassaganya-Riera. Nutritional protective mechanisms against gut inflammation. The Journal of Nutritional Biochemistry 2013; 24(6): 929 doi: 10.1016/j.jnutbio.2013.01.006
114
Des Field, Lisa Quigley, Paula M. O'Connor, Mary C. Rea, Karen Daly, Paul D. Cotter, Colin Hill, R. Paul Ross. Studies with bioengineered Nisin peptides highlight the broad‐spectrum potency of Nisin V. Microbial Biotechnology 2010; 3(4): 473 doi: 10.1111/j.1751-7915.2010.00184.x
115
Lauren C. Ahyow, Paul C. Lambert, David R. Jenkins, Keith R. Neal, Martin Tobin. Bed Occupancy Rates and Hospital-Acquired Clostridium difficile Infection: A Cohort Study. Infection Control & Hospital Epidemiology 2013; 34(10): 1062 doi: 10.1086/673156
116
Alyssa Liubakka, Byron P. Vaughn. Clostridium difficile Infection and Fecal Microbiota Transplant. AACN Advanced Critical Care 2016; 27(3): 324 doi: 10.4037/aacnacc2016703
117
Suresh Keshavamurthy, Colleen G. Koch, Thomas G. Fraser, Steven M. Gordon, Penny L. Houghtaling, Edward G. Soltesz, Eugene H. Blackstone, Gösta B. Pettersson. Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization. The Journal of Thoracic and Cardiovascular Surgery 2014; 148(6): 3157 doi: 10.1016/j.jtcvs.2014.08.017
118
Matthias G Hautmann, Matthias Hipp, Oliver Kölbl. Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?. Radiation Oncology 2011; 6(1) doi: 10.1186/1748-717X-6-89
119
Michelle M. Nerandzic, Curtis J. Donskey, Peter Setlow. Activate to Eradicate: Inhibition of Clostridium difficile Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin. PLoS ONE 2013; 8(1): e54740 doi: 10.1371/journal.pone.0054740
120
Yong-Sang Kim, Hong-Jun Jeon, Su-A Nam, Byung Moon Cho, Se-Hyuck Park, Se Moon Oh. Analysis of Clinical Characteristics and Risk Factors to Neurosurgical Patients withClostridium Difficile-Associated Diarrhea. Journal of Korean Neurotraumatology Society 2011; 7(2): 92 doi: 10.13004/jknts.2011.7.2.92
121
A. Castillo, J. López, E. Panadero, J. Cerdá, B. Padilla, A. Bustinza. Conservative surgical treatment for toxic megacolon due to Clostridium difficile infection in a transplanted pediatric patient. Transplant Infectious Disease 2012; 14(4) doi: 10.1111/j.1399-3062.2012.00756.x
122
Kelly C. Sandberg, Matthew M. Davis, Achamyeleh Gebremariam, Jeremy Adler. Disproportionate Rise in Clostridium difficile–Associated Hospitalizations Among US Youth With Inflammatory Bowel Disease, 1997–2011. Journal of Pediatric Gastroenterology and Nutrition 2015; 60(4): 486 doi: 10.1097/MPG.0000000000000636
123
A.R. Hosseindoust, S.H. Lee, J.S. Kim, Y.H. Choi, H.S. Noh, J.H. Lee, P.K. Jha, I.K. Kwon, B.J. Chae. Dietary bacteriophages as an alternative for zinc oxide or organic acids to control diarrhoea and improve the performance of weanling piglets. Veterinární medicína 2017; 62(2): 53 doi: 10.17221/7/2016-VETMED
124
Ying Nie, Qinlu Lin, Feijun Luo. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. International Journal of Molecular Sciences 2017; 18(7): 1372 doi: 10.3390/ijms18071372
125
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham, Charles E. Edmiston. Clostridium difficile. Journal of Parenteral and Enteral Nutrition 2012; 36(6): 645 doi: 10.1177/0148607112446703
126
M.J.G.T. Vehreschild, J.J. Vehreschild, K. Hübel, M. Hentrich, M. Schmidt-Hieber, M. Christopeit, G. Maschmeyer, E. Schalk, O.A. Cornely, S. Neumann. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Oncology 2013; 24(5): 1189 doi: 10.1093/annonc/mdt001
127
Ana Pérez-Cobas, Andrés Moya, María Gosalbes, Amparo Latorre. Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics 2015; 4(3): 337 doi: 10.3390/antibiotics4030337
128
Shankumar Mooyottu, Anup Kollanoor-Johny, Genevieve Flock, Laurent Bouillaut, Abhinav Upadhyay, Abraham Sonenshein, Kumar Venkitanarayanan. Carvacrol and trans-Cinnamaldehyde Reduce Clostridium difficile Toxin Production and Cytotoxicity in Vitro. International Journal of Molecular Sciences 2014; 15(3): 4415 doi: 10.3390/ijms15034415
129
Ming-fei WANG, Zhao DING, Jian ZHAO, Cong-qing JIANG, Zhi-su LIU, Qun QIAN. Current role of surgery for the treatment of fulminant Clostridium difficile colitis. Chinese Medical Journal 2013; 126(5): 949 doi: 10.3760/cma.j.issn.0366-6999.20111537
130
Manoj Kumar, Tarun Mathur, Tarani K. Barman, G. Ramkumar, Ashish Bhati, Gunjan Shukla, Vandana Kalia, Manisha Pandya, V. Samuel Raj, Dilip J. Upadhyay, Chetana Vaishnavi, Anjan Chakrabarti, Biswajit Das, Pradip K. Bhatnagar. In Vitro and In Vivo Activities of the Novel Ketolide RBx 14255 against Clostridium difficile . Antimicrobial Agents and Chemotherapy 2012; 56(11): 5986 doi: 10.1128/AAC.00015-12
131
Ellen Cesewski, Blake N. Johnson. Electrochemical biosensors for pathogen detection. Biosensors and Bioelectronics 2020; 159: 112214 doi: 10.1016/j.bios.2020.112214
132
Michelle D Cairns, Richard A Stabler, Nandini Shetty, Brendan W Wren. The continually evolving Clostridium difficile species. Future Microbiology 2012; 7(8): 945 doi: 10.2217/fmb.12.73
133
Martha R Herbert. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Current Opinion in Neurology 2010; 23(2): 103 doi: 10.1097/WCO.0b013e328336a01f
134
Ilana T. Balassiano, Joaquim dos Santos-Filho, Juliana M. Vital-Brazil, Simone A. Nouér, Claudia R. C. Souza, Jon S. Brazier, Eliane de O. Ferreira, Regina M. C. P. Domingues. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil. Antonie van Leeuwenhoek 2011; 99(2): 249 doi: 10.1007/s10482-010-9483-8
135
Chao Chen, Naveen K. Dolla, Gabriele Casadei, John B. Bremner, Kim Lewis, Michael J. Kelso. Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells. Bioorganic & Medicinal Chemistry Letters 2014; 24(2): 595 doi: 10.1016/j.bmcl.2013.12.015
136
Sayeda Nasrin Alam, Halim Yammine, Omeed Moaven, Rizwan Ahmed, Angela K. Moss, Brishti Biswas, Nur Muhammad, Rakesh Biswas, Atri Raychowdhury, Kanakaraju Kaliannan, Sathi Ghosh, Madhury Ray, Sulaiman R. Hamarneh, Soumik Barua, Nondita S. Malo, Atul K. Bhan, Madhu S. Malo, Richard A. Hodin. Intestinal Alkaline Phosphatase Prevents Antibiotic-Induced Susceptibility to Enteric Pathogens. Annals of Surgery 2014; 259(4): 715 doi: 10.1097/SLA.0b013e31828fae14
137
Darius Gawlik, Peter Slickers, Ines Engelmann, Elke Müller, Christian Lück, Anette Friedrichs, Ralf Ehricht, Stefan Monecke. DNA-Microarray-based Genotyping of Clostridium difficile . BMC Microbiology 2015; 15(1) doi: 10.1186/s12866-015-0489-2
138
Şükrü ÖKSÜZ, Ayşe DANIŞ, Elif ÖZTÜRK, Emel ÇALIŞKAN, Nida KILIÇ AKAR, Mehmet Ali SUNGUR. Hastanede uzun süreli yatan hastalarda Clostridium difficile kolonizasyonunun araştırılması. Anadolu Kliniği Tıp Bilimleri Dergisi 2017;  doi: 10.21673/anadoluklin.298926
139
Faith Rohlke, Neil Stollman. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therapeutic Advances in Gastroenterology 2012; 5(6): 403 doi: 10.1177/1756283X12453637
140
Yinghong Wang, Ashish Atreja, Xianrui Wu, Bret A. Lashner, Aaron Brzezinski, Bo Shen. Similar Outcomes of IBD Inpatients with Clostridium difficile Infection Detected by ELISA or PCR Assay. Digestive Diseases and Sciences 2013; 58(8): 2308 doi: 10.1007/s10620-013-2641-x
141
V. K. Viswanathan, Michael Mallozzi, Gayatri Vedantam. Clostridium difficileinfection. Gut Microbes 2010; 1(4): 234 doi: 10.4161/gmic.1.4.12706
142
Nuntra Suwantarat, David A. Bobak. Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection. Current Infectious Disease Reports 2011; 13(1): 21 doi: 10.1007/s11908-010-0155-7
143
Raquel Salazar-Kagunye, Anish Shah, Gina Loshkajian, Walid Baddoura, Vincent A DeBari. Association of decreased serum protein fractions with Clostridium difficile infection in the acute care setting: a case–control study. Biomarkers in Medicine 2012; 6(5): 663 doi: 10.2217/bmm.12.52
144
Jacek Czepiel, Mirosław Dróżdż, Hanna Pituch, Ed J. Kuijper, William Perucki, Aleksandra Mielimonka, Sarah Goldman, Dorota Wultańska, Aleksander Garlicki, Grażyna Biesiada. Clostridium difficile infection: review. European Journal of Clinical Microbiology & Infectious Diseases 2019; 38(7): 1211 doi: 10.1007/s10096-019-03539-6
145
Julio Cesar de Oliveira, Martino Martinelli, Andre D'Avila, Stephan Danik. Response to the Letter Regarding Article “Efficacy of Antibiotic Prophylaxis Before the Implantation of Pacemakers and Cardioverter-Defibrillators”. Circulation: Arrhythmia and Electrophysiology 2009; 2(3) doi: 10.1161/CIRCEP.109.877076
146
B. Guo, C. Harstall, T. Louie, S. Veldhuyzen van Zanten, L. A. Dieleman. Systematic review: faecal transplantation for the treatment of Clostridium difficile‐associated disease. Alimentary Pharmacology & Therapeutics 2012; 35(8): 865 doi: 10.1111/j.1365-2036.2012.05033.x
147
Michael J. Aldape, Aaron E. Packham, Dustin D. Heeney, Savannah N. Rice, Amy E. Bryant, Dennis L. Stevens. Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficile in vitro .  Journal of Medical Microbiology 2017; 66(10): 1393 doi: 10.1099/jmm.0.000580
148
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Kumar Venkitanarayanan. In vitro antivirulence activity of baicalin against Clostridioides difficile .  Journal of Medical Microbiology 2020; 69(4): 631 doi: 10.1099/jmm.0.001179
149
Ilana Teruszkin Balassiano, Joaquim dos Santos-Filho, Márcia Pinto Barros de Oliveira, Maria Catarina Ramos, Andre M. Japiassu, Alessandro Mendonça dos Reis, Jon S. Brazier, Eliane de Oliveira Ferreira, Regina Maria Cavalcanti Pilotto Domingues. An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil. Diagnostic Microbiology and Infectious Disease 2010; 68(4): 449 doi: 10.1016/j.diagmicrobio.2010.07.017
150
Michel R. Popoff, Philippe Bouvet. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 2013; 75: 63 doi: 10.1016/j.toxicon.2013.05.003
151
Abdulwahab Ali Abuderman, Ayesha Mateen, Rabbani Syed, Mustafa sawsan aloahd. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes. Microbial Pathogenesis 2018; 120: 1 doi: 10.1016/j.micpath.2018.04.013
152
P.-J. Maziade, J.A. Andriessen, P. Pereira, B. Currie, E.J.C. Goldstein. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital. Current Medical Research and Opinion 2013; 29(10): 1341 doi: 10.1185/03007995.2013.833501
153
I. T. Balassiano, E. A. Yates, R. M. C. P. Domingues, E. O. Ferreira. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. Journal of Medical Microbiology 2012; 61(2): 169 doi: 10.1099/jmm.0.037077-0
154
Resha Menon, Pushpa Mahadevan, Merin Jaison. Histopathological spectrum of infectious diseases in endoscopic mucosal biopsies of the gastrointestinal tract: A one-year study at a tertiary care hospital in Kerala. Indian Journal of Pathology and Oncology 2024; 11(1): 27 doi: 10.18231/j.ijpo.2024.006
155
Fabio Miyajima, Paul Roberts, Andrew Swale, Valerie Price, Maureen Jones, Michael Horan, Nicholas Beeching, Jonathan Brazier, Christopher Parry, Neil Pendleton, Munir Pirmohamed, Markus M. Heimesaat. Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom. PLoS ONE 2011; 6(8): e22804 doi: 10.1371/journal.pone.0022804
156
Michael John Aldape, Aaron Eugene Packham, Drew William Nute, Amy Evelyn Bryant, Dennis Leroy Stevens. Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile .  Journal of Medical Microbiology 2013; 62(5): 741 doi: 10.1099/jmm.0.056218-0
157
Hye Jung Cho, Eell Ryoo, Yong Han Sun, Kang Ho Cho, Dong Woo Son, Hann Tchah. Epidemiology and Clinical Characteristics ofClostridium difficile-associated Disease in Children: Comparison between Community- and Hospital-acquired Infections. Korean Journal of Pediatric Gastroenterology and Nutrition 2010; 13(2): 146 doi: 10.5223/kjpgn.2010.13.2.146
158
E. Hofer, H. Haechler, R. Frei, R. Stephan. Low Occurrence of Clostridium difficile in Fecal Samples of Healthy Calves and Pigs at Slaughter and in Minced Meat in Switzerland. Journal of Food Protection 2010; 73(5): 973 doi: 10.4315/0362-028X-73.5.973
159
Wasef Na’amnih, Amos Adler, Tamar Miller-Roll, Dani Cohen, Yehuda Carmeli. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel. European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(7): 1281 doi: 10.1007/s10096-018-3247-1
160
Jonathan Barra-Carrasco, Daniel Paredes-Sabja. Clostridium difficile spores: a major threat to the hospital environment. Future Microbiology 2014; 9(4): 475 doi: 10.2217/fmb.14.2
161
J. M. Wenisch, D. Schmid, H.-W. Kuo, E. Simons, F. Allerberger, V. Michl, P. Tesik, G. Tucek, C. Wenisch. Hospital-acquired Clostridium difficile infection: determinants for severe disease. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(8): 1923 doi: 10.1007/s10096-011-1522-5
162
Moacyr Silva Júnior. Recent changes in Clostridium difficile infection. Einstein (São Paulo) 2012; 10(1): 105 doi: 10.1590/S1679-45082012000100023
163
Akira Andoh, Shigeki Bamba. Current Status of <I>Clostridium Difficile</I> Infection. Nippon Daicho Komonbyo Gakkai Zasshi 2018; 71(10): 456 doi: 10.3862/jcoloproctology.71.456
164
Giuseppe Caramia, Stefania Silvi. Probiotic Bacteria and Enteric Infections. 2011; : 3 doi: 10.1007/978-94-007-0386-5_1
165
Helga Häfner, Susanne Koch, Sebastian Lemmen. Die Intensivmedizin. 2011; : 801 doi: 10.1007/978-3-642-16929-8_64
166
J. Viala, M. Lorrot, L. Pull, P. Mariani-Kurkdjian, L. Paris, M. Bellaïche, A. Smail, J.-Y. Siriez. Gastroentérites aiguës de l’enfant. EMC - Maladies infectieuses 2013; 10(1): 1 doi: 10.1016/S1166-8598(12)57862-2
167
M. Parthasarathy, D. Bowers, T. Groot‐Wassink. Do preoperative oral antibiotics increase Clostridium difficile infection rates? An analysis of 13 959 colectomy patients. Colorectal Disease 2018; 20(6): 520 doi: 10.1111/codi.13926
168
Sean Fitzwater, Aruna Chandran, Margaret Kosek, Mathuram Santosham. Water and Sanitation‐Related Diseases and the Environment. 2011; : 47 doi: 10.1002/9781118148594.ch5
169
Tammy A. Novotne, Hatem O. Kaseb. The changing face of Clostridium difficile in critical care. Nursing Critical Care 2013; 8(3): 26 doi: 10.1097/01.CCN.0000429383.25720.13
170
Jason Fawley, David M. Gourlay. Intestinal alkaline phosphatase: a summary of its role in clinical disease. Journal of Surgical Research 2016; 202(1): 225 doi: 10.1016/j.jss.2015.12.008
171
Massimo Sartelli, Stefano Di Bella, Lynne V. McFarland, Sahil Khanna, Luis Furuya-Kanamori, Nadir Abuzeid, Fikri M. Abu-Zidan, Luca Ansaloni, Goran Augustin, Miklosh Bala, Offir Ben-Ishay, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria E. Cocuz, Raul Coimbra, Francesco Cortese, Yunfeng Cui, Jacek Czepiel, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina M. Dumitru, Christian Eckmann, Edward H. Eiland, Joseph D. Forrester, Gustavo P. Fraga, Jean L. Frossard, Donald E. Fry, Rita Galeiras, Wagih Ghnnam, Carlos A. Gomes, Ewen A. Griffiths, Xavier Guirao, Mohamed H. Ahmed, Torsten Herzog, Jae Il Kim, Tariq Iqbal, Arda Isik, Kamal M. F. Itani, Francesco M. Labricciosa, Yeong Y. Lee, Paul Juang, Aleksandar Karamarkovic, Peter K. Kim, Yoram Kluger, Ari Leppaniemi, Varut Lohsiriwat, Gustavo M. Machain, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick A. Moore, Carlos A. Ordoñez, Leonardo Pagani, Nicola Petrosillo, Francisco Portela, Kemal Rasa, Miran Rems, Boris E. Sakakushev, Helmut Segovia-Lohse, Gabriele Sganga, Vishal G. Shelat, Patrizia Spigaglia, Pierre Tattevin, Cristian Tranà, Libor Urbánek, Jan Ulrych, Pierluigi Viale, Gian L. Baiocchi, Fausto Catena. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World Journal of Emergency Surgery 2019; 14(1) doi: 10.1186/s13017-019-0228-3
172
Michel R Popoff, Philippe Bouvet. Clostridial toxins. Future Microbiology 2009; 4(8): 1021 doi: 10.2217/fmb.09.72
173
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, Jochen Maul, Yami Shapira, Daniela Bojic, Irit Chermesh, Ahmad Al-Rifai, Alain Schoepfer, Matteo Bosani, Matthieu Allez, Peter Laszlo Lakatos, Fabrizio Bossa, Alexander Eser, Tommaso Stefanelli, Franck Carbonnel, Konstantinos Katsanos, Davide Checchin, Inés Sáenz de Miera, Walter Reinisch, Yehuda Chowers, Gordon William Moran. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. Journal of Crohn's and Colitis 2010; 4(2): 194 doi: 10.1016/j.crohns.2009.11.001
174
Jacyntha A. Sterling. Recent Publications on Medications and Pharmacy. Hospital Pharmacy 2009; 44(6): 526 doi: 10.1310/hpj4406-526
175
Lawrence J. Brandt, Sheela S. Reddy. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Journal of Clinical Gastroenterology 2011; 45: S159 doi: 10.1097/MCG.0b013e318222e603
176
Helena Lomba Viana. Clostridium difficile: infeção e ribotipos. GE Jornal Português de Gastrenterologia 2013; 20(6): 240 doi: 10.1016/j.jpg.2013.09.001
177
Sean Fitzwater, Anita Shet, Mathuram Santosham, Margaret Kosek. Water and Sanitation‐Related Diseases and the Changing Environment. 2019; : 63 doi: 10.1002/9781119415961.ch7
178
Michael John Aldape, Savannah Nicole Rice, Kevin Patrick Field, Amy Evelyn Bryant, Dennis Leroy Stevens. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro. Journal of Medical Microbiology 2018; 67(12): 1689 doi: 10.1099/jmm.0.000852
179
Khalid A Osman, Mohamed H Ahmed, Mahir A Hamad, Dilip Mathur. Emergency colectomy for fulminantClostridium difficilecolitis: Striking the right balance. Scandinavian Journal of Gastroenterology 2011; 46(10): 1222 doi: 10.3109/00365521.2011.605469
180
Gizem ADAN, Nafiye URGANCI, Ayşe Ayşim ÖZAĞARI. Clostiridium difficile enfeksiyonuna eşlik eden protein kaybettiren enteropati olgusu. Akademik Gastroenteroloji Dergisi 2022; 21(1): 48 doi: 10.17941/agd.1100119
181
Alicia R. Desilets, Nicole J. Asal, Kaelen C. Dunican. Considerations for the Use of Proton-Pump Inhibitors in Older Adults. The Consultant Pharmacist 2012; 27(2): 114 doi: 10.4140/TCP.n.2012.114
182
Pamela Sears, Yoshi Ichikawa, Nancy Ruiz, Sherwood Gorbach. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic. Annals of the New York Academy of Sciences 2013; 1291(1): 33 doi: 10.1111/nyas.12135
183
Clara Lina Salazar, Catalina Reyes, Astrid Vanessa Cienfuegos-Gallet, Emma Best, Santiago Atehortua, Patricia Sierra, Margarita M. Correa, Warren N. Fawley, Daniel Paredes-Sabja, Mark Wilcox, Angel Gonzalez, Baochuan Lin. Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia. PLOS ONE 2018; 13(4): e0195694 doi: 10.1371/journal.pone.0195694
184
Elizabeth J. Kvach, David Ferguson, Paul F. Riska, Marie L. Landry. Comparison of BD GeneOhm Cdiff Real-Time PCR Assay with a Two-Step Algorithm and a Toxin A/B Enzyme-Linked Immunosorbent Assay for Diagnosis of Toxigenic Clostridium difficile Infection . Journal of Clinical Microbiology 2010; 48(1): 109 doi: 10.1128/JCM.01630-09
185
Stefano Di Bella, Gianfranco Sanson, Jacopo Monticelli, Verena Zerbato, Luigi Principe, Mauro Giuffrè, Giuseppe Pipitone, Roberto Luzzati, Christopher Staley, Mayuresh Abhyankar. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options . Clinical Microbiology Reviews 2024;  doi: 10.1128/cmr.00135-23
186
Lynne V McFarland. Emerging therapies forClostridium difficileinfections. Expert Opinion on Emerging Drugs 2011; 16(3): 425 doi: 10.1517/14728214.2011.571204
187
Mehdi Goudarzi, Hossein Goudarzi, Masoud Alebouyeh, Masoumeh Azimi Rad, Farahnaz Sadat Shayegan Mehr, Mohammad Reza Zali, Mohammad Mehdi Aslani. Antimicrobial Susceptibility of Clostridium Difficile Clinical Isolates in Iran. Iranian Red Crescent Medical Journal 2013; 15(8): 704 doi: 10.5812/ircmj.5189
188
Danielle Angst Secco, Ilana Teruszkin Balassiano, Renata Ferreira Boente, Karla Rodrigues Miranda, Jon Brazier, Val Hall, Joaquim dos Santos-Filho, Leandro Araujo Lobo, Simone Aranha Nouér, Regina Maria Cavalcanti Pilotto Domingues. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain. Anaerobe 2014; 28: 85 doi: 10.1016/j.anaerobe.2014.05.013
189
Abhinav Upadhyay, Shankumar Mooyottu, Hsinbai Yin, Meera Nair, Varunkumar Bhattaram, Kumar Venkitanarayanan. Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts. Medicines 2015; 2(3): 186 doi: 10.3390/medicines2030186
190
X. Wu, P. T. Cherian, R. E. Lee, J. G. Hurdle. The membrane as a target for controlling hypervirulent Clostridium difficile infections. Journal of Antimicrobial Chemotherapy 2013; 68(4): 806 doi: 10.1093/jac/dks493
191
A. Sarkar, C.S. Pitchumoni. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 37 doi: 10.1016/B978-0-12-804024-9.00004-5
192
Rebecca Swett, G. Andrés Cisneros, Andrew L. Feig, Jörg Langowski. Conformational Analysis of Clostridium difficile Toxin B and Its Implications for Substrate Recognition. PLoS ONE 2012; 7(7): e41518 doi: 10.1371/journal.pone.0041518
193
Matthew J. Delano, Joseph Cuschieri. Surgical Management of Clostridium difficile Infection: The Role of Colectomy. Surgical Infections 2016; 17(3): 343 doi: 10.1089/sur.2016.004
194
Diagnostic Imaging: Pediatrics. 2017; : 526 doi: 10.1016/B978-0-323-44306-7.50191-2
195
Junichi Sasaki. Judicious use of antimicrobial agents in a field of emergency and critical care. Nihon Kyukyu Igakukai Zasshi 2010; 21(11): 871 doi: 10.3893/jjaam.21.871
196
Maria Carmen Collado, Erika Isolauri, Kirsi Laitinen, Seppo Salminen. Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. The American Journal of Clinical Nutrition 2010; 92(5): 1023 doi: 10.3945/ajcn.2010.29877
197
Theresa D. Ho, Craig D. Ellermeier, A. Camilli. PrsW Is Required for Colonization, Resistance to Antimicrobial Peptides, and Expression of Extracytoplasmic Function σ Factors in Clostridium difficile. Infection and Immunity 2011; 79(8): 3229 doi: 10.1128/IAI.00019-11
198
Rosanna Leuzzi, Janice Spencer, Anthony Buckley, Cecilia Brettoni, Manuele Martinelli, Lorenza Tulli, Sara Marchi, Enrico Luzzi, June Irvine, Denise Candlish, Daniele Veggi, Werner Pansegrau, Luigi Fiaschi, Silvana Savino, Erwin Swennen, Osman Cakici, Ernesto Oviedo-Orta, Monica Giraldi, Barbara Baudner, Nunzia D'Urzo, Domenico Maione, Marco Soriani, Rino Rappuoli, Mariagrazia Pizza, Gillian R. Douce, Maria Scarselli, B. A. McCormick. Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments. Infection and Immunity 2013; 81(8): 2851 doi: 10.1128/IAI.01341-12
199
Joao B. Rezende-Neto, Ori D. Rotstein. Abdominal Catastrophes in the Intensive Care Unit Setting. Critical Care Clinics 2013; 29(4): 1017 doi: 10.1016/j.ccc.2013.06.005
200
Shankumar Mooyottu, Genevieve Flock, Anup Kollanoor-Johny, Indu Upadhyaya, Bhushan Jayarao, Kumar Venkitanarayanan. Characterization of a multidrug resistant C. difficile meat isolate. International Journal of Food Microbiology 2015; 192: 111 doi: 10.1016/j.ijfoodmicro.2014.10.002
201
Victoria Blackwell, Simon Travis. Toxic dilatation of the colon. Medicine 2011; 39(2): 105 doi: 10.1016/j.mpmed.2010.11.002
202
Kai B. Dallas, Audree Condren, Celia M. Divino. Life after colectomy for fulminant Clostridium difficile colitis: a 7-year follow up study. The American Journal of Surgery 2014; 207(4): 533 doi: 10.1016/j.amjsurg.2013.04.008
203
Meenakshi Singh, Chetana Vaishnavi, Safrun Mahmood, Rakesh Kochhar. Toxinotyping and Sequencing of Clostridium difficile Isolates from Patients in a Tertiary Care Hospital of Northern India. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00033
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345